Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucosal immunization against respiratory bacterial pathogens.

A Ruth Foxwell1, Jennelle M Kyd, Allan W Cripps

  • 1Gadi Research Centre for Medical and Health Sciences, University of Canberra, Canberra ACT 2601, Australia. ruth.foxwell@canberra.edu.au

Expert Review of Vaccines
|January 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut Microbiome and Metabolic and Immune Indices in Males with or without Evidence of Metabolic Dysregulation.

Journal of obesity & metabolic syndrome·2024
Same author

Assessment of a Multispecies Probiotic Supplement for Relief of Seasonal Allergic Rhinitis: A Randomized Double-Blind Placebo-Controlled Trial.

Journal of integrative and complementary medicine·2023
Same author

Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable <i>Haemophilus influenzae</i> Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children.

Frontiers in cellular and infection microbiology·2022
Same author

Predominant Bacterial and Viral Otopathogens Identified Within the Respiratory Tract and Middle Ear of Urban Australian Children Experiencing Otitis Media Are Diversely Distributed.

Frontiers in cellular and infection microbiology·2022
Same author

The impacts of faecal subsampling on microbial compositional profiling.

BMC research notes·2022
Same author

Nasal immune gene expression in response to azelastine and fluticasone propionate combination or monotherapy.

Immunity, inflammation and disease·2021

Antibiotic resistance is rising in bacterial respiratory diseases affecting all ages. New non-injectable vaccines and mucosal immunity strategies are needed for effective prevention and treatment.

Area of Science:

  • Microbiology
  • Immunology
  • Public Health

Background:

  • Bacterial respiratory diseases cause significant global morbidity and mortality, especially in the young and elderly.
  • Current therapies rely on antibiotics, exacerbating antibiotic resistance issues.
  • Key pathogens include Mycobacterium tuberculosis, Streptococcus pneumoniae, and Pseudomonas aeruginosa.

Purpose of the Study:

  • To review current challenges in bacterial respiratory disease therapy and prevention.
  • To highlight the need for improved vaccines and delivery systems.
  • To emphasize the importance of mucosal immunity in combating respiratory pathogens.

Main Methods:

  • Literature review of bacterial respiratory pathogens and current treatment/prevention strategies.

Related Experiment Videos

  • Analysis of vaccine efficacy and accessibility limitations.
  • Discussion of challenges in developing novel immunization approaches.

    • Main Results:

    • Existing vaccines have limitations in accessibility and efficacy.
    • Antibiotic resistance is a growing concern in treating bacterial respiratory infections.
    • Optimal host response at the respiratory mucosal surface is crucial for infection control.

    Conclusions:

    • Development of non-injectable vaccines is a significant unmet need.
    • Improved immunization regimens are required to enhance mucosal immunity.
    • Novel strategies are essential for effective therapy and prevention of bacterial respiratory diseases.